These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 39236232)

  • 21. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation.
    Machlus KR; Thon JN; Italiano JE
    Br J Haematol; 2014 Apr; 165(2):227-36. PubMed ID: 24499183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.
    Panuganti S; Schlinker AC; Lindholm PF; Papoutsakis ET; Miller WM
    Tissue Eng Part A; 2013 Apr; 19(7-8):998-1014. PubMed ID: 23190353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The spectrin-based membrane skeleton stabilizes mouse megakaryocyte membrane systems and is essential for proplatelet and platelet formation.
    Patel-Hett S; Wang H; Begonja AJ; Thon JN; Alden EC; Wandersee NJ; An X; Mohandas N; Hartwig JH; Italiano JE
    Blood; 2011 Aug; 118(6):1641-52. PubMed ID: 21566095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
    Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
    Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-125a-5p regulates megakaryocyte proplatelet formation via the actin-bundling protein L-plastin.
    Bhatlekar S; Manne BK; Basak I; Edelstein LC; Tugolukova E; Stoller ML; Cody MJ; Morley SC; Nagalla S; Weyrich AS; Rowley JW; O'Connell RM; Rondina MT; Campbell RA; Bray PF
    Blood; 2020 Oct; 136(15):1760-1772. PubMed ID: 32844999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cdc42-dependent F-actin dynamics drive structuration of the demarcation membrane system in megakaryocytes.
    Antkowiak A; Viaud J; Severin S; Zanoun M; Ceccato L; Chicanne G; Strassel C; Eckly A; Leon C; Gachet C; Payrastre B; Gaits-Iacovoni F
    J Thromb Haemost; 2016 Jun; 14(6):1268-84. PubMed ID: 26991240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADF/n-cofilin-dependent actin turnover determines platelet formation and sizing.
    Bender M; Eckly A; Hartwig JH; Elvers M; Pleines I; Gupta S; Krohne G; Jeanclos E; Gohla A; Gurniak C; Gachet C; Witke W; Nieswandt B
    Blood; 2010 Sep; 116(10):1767-75. PubMed ID: 20530287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.
    Haddad E; Cramer E; Rivière C; Rameau P; Louache F; Guichard J; Nelson DL; Fischer A; Vainchenker W; Debili N
    Blood; 1999 Jul; 94(2):509-18. PubMed ID: 10397718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
    Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
    Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The formin DIAPH1 (mDia1) regulates megakaryocyte proplatelet formation by remodeling the actin and microtubule cytoskeletons.
    Pan J; Lordier L; Meyran D; Rameau P; Lecluse Y; Kitchen-Goosen S; Badirou I; Mokrani H; Narumiya S; Alberts AS; Vainchenker W; Chang Y
    Blood; 2014 Dec; 124(26):3967-77. PubMed ID: 25298036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes.
    Murai K; Kowata S; Shimoyama T; Yashima-Abo A; Fujishima Y; Ito S; Ishida Y
    Eur J Haematol; 2014 Oct; 93(4):290-6. PubMed ID: 24750292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proplatelet formation deficit and megakaryocyte death contribute to thrombocytopenia in Myh9 knockout mice.
    Eckly A; Rinckel JY; Laeuffer P; Cazenave JP; Lanza F; Gachet C; Léon C
    J Thromb Haemost; 2010 Oct; 8(10):2243-51. PubMed ID: 20695978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proplatelet generation in the mouse requires PKCε-dependent RhoA inhibition.
    Gobbi G; Mirandola P; Carubbi C; Masselli E; Sykes SM; Ferraro F; Nouvenne A; Thon JN; Italiano JE; Vitale M
    Blood; 2013 Aug; 122(7):1305-11. PubMed ID: 23838351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
    Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
    Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCL5 derived from platelets increases megakaryocyte proplatelet formation.
    Machlus KR; Johnson KE; Kulenthirarajan R; Forward JA; Tippy MD; Soussou TS; El-Husayni SH; Wu SK; Wang S; Watnick RS; Italiano JE; Battinelli EM
    Blood; 2016 Feb; 127(7):921-6. PubMed ID: 26647394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel insights into mouse models of ectopic proplatelet release.
    Spindler M; Bergmeier W; Stradal TEB; Zhang J; Siminovitch KA; Nicolai L; Reinhold A; Bender M
    Blood Adv; 2022 Dec; 6(24):6135-6139. PubMed ID: 36251748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes.
    Balduini A; Pallotta I; Malara A; Lova P; Pecci A; Viarengo G; Balduini CL; Torti M
    J Thromb Haemost; 2008 Nov; 6(11):1900-7. PubMed ID: 18752571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoskeletal mechanics of proplatelet maturation and platelet release.
    Thon JN; Montalvo A; Patel-Hett S; Devine MT; Richardson JL; Ehrlicher A; Larson MK; Hoffmeister K; Hartwig JH; Italiano JE
    J Cell Biol; 2010 Nov; 191(4):861-74. PubMed ID: 21079248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms.
    Espasandin YR; Glembotsky AC; Grodzielski M; Lev PR; Goette NP; Molinas FC; Marta RF; Heller PG
    J Thromb Haemost; 2015 Apr; 13(4):631-42. PubMed ID: 25604267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle-dependent centrosome clustering precedes proplatelet formation.
    Becker IC; Wilkie AR; Nikols E; Carminita E; Roweth HG; Tilburg J; Sciaudone AR; Noetzli LJ; Fatima F; Couldwell G; Ray A; Mogilner A; Machlus KR; Italiano JE
    Sci Adv; 2024 Jun; 10(25):eadl6153. PubMed ID: 38896608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.